S Dai Selected Research

S Dai Research Topics

Disease

3	Neoplasms (Cancer) 12/2017 - 05/2014
2	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2014 - 02/2008
2	Ulcer 05/2001 - 02/2000
2	Hemorrhage 05/2001 - 02/2000
2	Duodenal Ulcer (Curling's Ulcer) 05/2001 - 02/2000
1	Cardiotoxicity 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Chronic Renal Insufficiency 03/2019
1	Retinoschisis (Retinoschisis, Juvenile) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Esophageal Squamous Cell Carcinoma 04/2016
1	Lymphoma (Lymphomas) 12/2014
1	Respiratory Insufficiency (Respiratory Failure) 12/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2014
1	Autoimmune Diseases (Autoimmune Disease) 12/2014
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2014
1	Fibrosis (Cirrhosis) 12/2014
1	Hepatocellular Carcinoma (Hepatoma) 05/2014
1	Hypertension (High Blood Pressure) 03/2012
1	Osteopetrosis 09/2011
1	Cholangiocarcinoma 11/2009
1	Brain Edema (Cerebral Edema) 02/2008
1	Parkinson Disease (Parkinson's Disease) 02/2008
1	Brain Injuries (Brain Injury) 02/2008
1	Stroke (Strokes) 02/2008
1	Autolysis 08/2001
1	Endometriosis 06/2000
1	Thyroid Neoplasms (Thyroid Cancer) 04/2000
1	Peptic Ulcer (Peptic Ulcers) 02/2000

Drug/Important Bio-Agent (IBA)

2	Glutamic Acid (Glutamate)FDA Link 04/2014 - 02/2008
2	Omeprazole (Prilosec)FDA LinkGeneric 05/2001 - 02/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	AnthracyclinesIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Hemodialysis SolutionsIBA 03/2019
1	Retinaldehyde (Retinal)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 12/2017
1	DNA (Deoxyribonucleic Acid)IBA 12/2017
1	Translationally-Controlled 1 Tumor ProteinIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2017
1	Radiation-Sensitizing AgentsIBA 04/2016
1	olaparibIBA 04/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2016
1	Monoclonal AntibodiesIBA 12/2014
1	InflammasomesIBA 12/2014
1	Immunoglobulin G (IgG)IBA 12/2014
1	Rituximab (Mabthera)FDA Link 12/2014
1	Inosine Triphosphate (ITP)IBA 12/2014
1	SteroidsIBA 12/2014
1	Cyclin D1IBA 05/2014
1	Cyclin B1IBA 05/2014
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2014
1	Homer Scaffolding Proteins (Homer 1)IBA 04/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 09/2011
1	Biomarkers (Surrogate Marker)IBA 11/2009
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2009
1	Psychotropic Drugs (Psychoactive Drugs)IBA 02/2008
1	CytokinesIBA 02/2008
1	Purinergic P1 Receptor AntagonistsIBA 02/2008
1	Neuroprotective AgentsIBA 02/2008
1	Caffeine (No Doz)FDA LinkGeneric 02/2008
1	Drinking WaterIBA 02/2008
1	Methanol (Carbinol)IBA 08/2001
1	EnzymesIBA 08/2001
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2001
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2001
1	Interferon-gamma (Interferon, gamma)IBA 06/2000
1	Interleukin-4 (Interleukin 4)IBA 06/2000
1	Amino Acids FDA Link 04/2000
1	delta proteinIBA 04/2000
1	Cimetidine (Biomet)FDA LinkGeneric 02/2000

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2017 - 03/2012
1	Radiotherapy 04/2016
1	Lasers (Laser) 11/2009
1	Intravenous Infusions 05/2001
1	Endoscopes 05/2001